GeneDx Holdings (WGS) Current Assets (2020 - 2026)

GeneDx Holdings has disclosed Current Assets across 7 years of filings, most recently posting $270.6 million for Q1 2026.

• In Q1 2026, Current Assets rose 19.84% year-over-year to $270.6 million; the TTM figure through Mar 2026 stood at $270.6 million (up 19.84% YoY), while the FY2025 annual figure was $268.3 million, up 35.52% from the prior year.
• Current Assets rose to $270.6 million in Q1 2026, from $268.3 million in the prior quarter.
• Over the last five years, Current Assets for WGS reached as high as $410.4 million in Q1 2022 and fell as low as $162.2 million in Q2 2024.
• The 5-year median for Current Assets is $213.3 million (2023), against an average of $240.5 million.
• The widest YoY moves for Current Assets: up 306.72% in 2022, down 56.03% in 2022.
• A 5-year view of Current Assets shows it stood at $212.6 million in 2022, then decreased by 14.24% to $182.3 million in 2023, then advanced by 8.57% to $198.0 million in 2024, then soared by 35.52% to $268.3 million in 2025, then grew by 0.87% to $270.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $270.6 million, $268.3 million, and $237.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.